InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+10.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Danziger Asaf, 董事长兼首席执行官. Officer active across 1 company, notably NovoCure Ltd. In total, 10 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €353k. Activity tracked since 6 July 2021. The latest transaction was disclosed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Danziger Asaf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
268 股Ordinary SharesSEC:0001654435-26-000003:0
833 股@ US$15.131.5% 占其流量Ordinary SharesSEC:0001562180-25-005187:0
412 股@ US$14.7480.6% 占其流量Ordinary SharesSEC:0001562180-25-000065:0
1,239 股@ US$12.241.3% 占其流量Ordinary SharesSEC:0001562180-24-006041:0
367 股@ US$35.281.1% 占其流量Ordinary SharesSEC:0001562180-23-005755:0
25,000 股@ US$11.4625.6% 占其流量Ordinary SharesSEC:0001645113-23-000007:0
276 股@ US$59.0751.5% 占其流量Ordinary SharesSEC:0001645113-22-000062:0
31 股@ US$63.8180.3% 占其流量Ordinary SharesSEC:0001645113-22-000004:0
3,870 股@ US$102.3650.7% 占其流量Ordinary SharesSEC:0001645113-21-000116:0
标准退出：2022年2月24日 (T+90)
118 股@ US$137.1222.0% 占其流量Ordinary SharesSEC:0001645113-21-000084:0
10 条申报中的 10 条
About Danziger Asaf
Danziger Asaf is President and Chief Executive Officer and is a director of NovoCure Ltd (XNAS). He has 10 filings in total, and across the sampled recent filings, buys amount to EUR 353386 and sells to EUR 0, between 2021-07-08 and 2026-07-01, with Attribution as the modal transaction nature.
